References
- Mahley RW, Innerarity TL, Brown MS, et al. Cholesteryl ester synthesis in macrophages: stimulation by beta—very low density lipoproteins from cholesterol-fed animals of several species. J Lipid Res 1980: 21(8): 970–80
- Keidar S, Goldberg AC, Cook K, et al. A high carbohydrate—fat free diet alters the proportion of heparin-bound VLDL in plasma and the expression of VLDL-apoB-100 epitopes. Metabolism 1990: 39(3): 281–8
- Barrett-Connor E, Wingard DL, Criqui MH. Postmenopausal estrogen use and heart disease risk factors in the 1980s: Rancho Bernardo, Calif, revisited. JAMA 1989: 261(14): 2095–100
- Henderson BE, Paganini-Hill A, Ross RK. Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol 1988;159(2): 312–7 [erratum, Am J Obstet Gynecol 1988: 159(6): 1574]
- Hulley SB, Gordon S. Alcohol and high-density lipoprotein cholesterol: causal inference from diverse study designs. Circulation 1981: 64(3 Pt 2): III57–63
- Witztum JL, Schonfeld G, Weidman SW. The effects of colestipol on the metabolism of very-low-density lipoproteins in man. J Lab Clin Med 1976: 88(6): 1008–18
- Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988: 37(12): 1595–607
- Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989: 149(7): 1514–20
- Williams RR, Hunt SC, Hopkins PN, et al. Familial dyslipidemic hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988: 259(24): 3579–86
- Manninen V, Tenkanen L, Koskinen P, et al. Serum triglycerides and coronary heart disease in the Helsinki Heart Study. Circulation (in press)
- Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand 1988: 223(5): 405–18